Back to top
more

Amgen Inc: (AMGN)

(Market Close from NSDQ)

 Add to portfolio

Save at Trade

$174.80 USD

174.80
2,423,035

-0.79 (-0.45%)

Updated Aug 4, 2015 04:14 PM ET

Volume: 2,423,035

Open: $175.79

Prior Close: $175.59

Zacks Rank : 2-Buy [?]   2      

Style Scores [?] : Growth: D | Value: C | Momentum: C

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

After-Market: $174.82 +0.02 (0.01%) 7:52 PM ET

Company Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

General Information

AMGEN INC

ONE AMGEN CENTER DRIVE

THOUSAND OAKS, CA 91320

Phone: 805-447-1000

Fax: 805-447-1010

Web: http://www.amgen.com

Email: investor.relations@amgen.com

Industry MED-BIOMED/GENE
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2015
Next EPS Date 10/26/2015

EPS Information

Current Quarter EPS Consensus Estimate 2.36
Current Year EPS Consensus Estimate 9.70
Estimated Long-Term EPS Growth Rate 9.50
Next EPS Report Date 10/26/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 175.59
52 Week High 181.81
52 Week Low 124.76
Beta 0.53
20 Day Moving Average 2,802,039.50
Target Price Consensus 181.09

AMGN

% Price Change
4 Week 15.22
12 Week 11.84
YTD 7.78
% Price Change Relative to S&P 500
4 Week 13.74
12 Week 10.99
YTD -1.43
Share Information
Shares Outstanding (millions) 760.32
Market Capitalization (millions) 134,265.61
Short Ratio 2.86
Last Split Date 11/22/1999
Dividend Information
Dividend Yield 1.79%
Annual Dividend $3.16
Payout Ratio 0.34
Change in Payout Ratio NA
Last Dividend Payout / Amount 5/12/2015 / $0.79

Fundamental Ratios

P/E
P/E (F1) 18.38
Trailing 12 Months 18.57
PEG Ratio 1.94
EPS Growth
vs. Previous Year 8.44%
vs. Previous Quarter 3.63%
   
Sales Growth
vs. Previous Year 3.67%
vs. Previous Quarter 6.70%
   
Price Ratios
Price/Book 5.07
Price/Cash Flow 15.29
Price / Sales 6.47
ROE
6/30/15 NA
3/31/15 28.11
12/31/14 27.24
ROA
6/30/15 NA
3/31/15 10.30
12/31/14 9.68
Current Ratio
6/30/15 NA
3/31/15 5.53
12/31/14 4.95
Quick Ratio
6/30/15 NA
3/31/15 5.11
12/31/14 4.58
Operating Margin
6/30/15 NA
3/31/15 34.84
12/31/14 33.34
Net Margin
6/30/15 NA
3/31/15 27.74
12/31/14 25.71
Pre-Tax Margin
6/30/15 NA
3/31/15 30.41
12/31/14 27.84
Book Value
6/30/15 NA
3/31/15 34.86
12/31/14 33.92
Inventory Turnover
6/30/15 NA
3/31/15 1.56
12/31/14 1.54
Debt-to-Equity
6/30/15 NA
3/31/15 1.13
12/31/14 1.17
Debt to Capital
6/30/15 NA
3/31/15 52.96
12/31/14 53.96